Skip to content
Open access

Buccal DNA Methylation-Derived EpiScores are Associated with Neonatal Morbidity Burden in Infants born Very Preterm

Sep 2026 · medRxiv · 0 citations · 5 references
Medicine

TL;DR

B Buccal DNA methylation-derived EpiScores capture biological signatures associated with neonatal morbidity burden in very preterm infants, and reflected immune, inflammatory, metabolic, and growth-related pathways.

Abstract

Background: Infants <30 weeks gestational age (very preterm (VPT)), are at risk of experiencing multiple serious neonatal morbidities. These morbidities impart serious biological stress, which may be reflected in dysregulated protein expression even after the morbidities have resolved. Recent studies suggest that DNA methylation-based predictors of circulating proteins may reflect the molecular effects of neonatal adversity. The objective of this study is to examine associations between DNA methylation-derived EpiScores, which are externally trained methylation signatures that proxy circulating protein levels, and neonatal morbidity burden in children born VPT. Buccal DNA methylation was obtained at NICU discharge in 537 infants from the NOVI cohort. A total of 111 EpiScores were calculated and tested for association with multimorbidity (0-1 vs. [≥] 2 morbidities) using adjusted linear regression models. Cross-tissue analyses in an external paired blood-buccal dataset (n=21) were used to identify EpiScores with moderate-to-strong correlations across tissues. Results: Eighteen EpiScores were nominally associated with multimorbidity (p < 0.05), with Melanoma-derived growth regulatory protein (MIA) with FDR < 0.05 (beta = 0.0023, p = 0.0004). In cross-tissue analyses, 35 EpiScores yielded r > 0.50 (p<0.05), 11 of which showed nominal associations with multimorbidity, including MIA. Overall, the morbidity-associated EpiScores reflected immune, inflammatory, metabolic, and growth-related pathways. Conclusions: Buccal DNA methylation-derived EpiScores capture biological signatures associated with neonatal morbidity burden in very preterm infants.

Read PDF

Similar papers

Open access Aug 2026

DNA methylation signal of birthweight generalizes to high-risk pregnancies and is independent of genetic, maternal, and obstetric factors: a twin study

DNA methylation is associated with individual differences in birthweight in a high-risk clinical population of MC twins, independent of shared genetic, familial, maternal, and obstetric factors.

M. Sulaiman, L. Franken, J. A. Spekman et al. · 0 citations
Sep 2026

Epigenome-Wide Placental Methylation Landscapes in Relation to Antenatal Depressive Symptoms.

Preliminary evidence of DNA methylation signatures linked to potential candidate genes and biological pathways that may be relevant to ADS are provided, supporting the need for validation in larger independent cohorts and functional experimental studies.

C. Thirumoorthy, S. S. Nair, M. Deepa et al. · 0 citations
Open access Oct 2026

T-cell dysregulation is implicated in the encephalopathy of prematurity

Preterm birth is strongly linked to systemic inflammation and encephalopathy of prematurity, which underlies subsequent cognitive impairment. T-cell immunity contributes to brain-immune crosstalk across the life course but its role in the pathogenesis of encephalopathy of prematurity is unknown. Protein epigenetic scor...

R. Smikle-Bernard, M. B. Cabez, K. Vaher et al. · 0 citations
Review Aug 2026

Methylation profile scores in child and adolescent health: a practical guide.

Most MPSs are better characterised as research tools at an early stage of development rather than clinical tools, and are highlighted as research tools at an early stage of development rather than clinical tools.

I. Schuurmans, S. Defina, A. P. C. Hermans et al. · 0 citations
Open access Oct 2026

Preterm Risk Factors, Epigenetic Age, and Neurodevelopmental Outcomes

The findings suggests that the association between epigenetic aging and neurodevelopment among children born preterm is context dependent and can vary based on the presence of preterm risk factors.

R. Christensen, Chaini Konwar, Beryl C. Zhuang et al. · 0 citations
Open access Sep 2026

Maternal Epigenetic Signatures Linking Prenatal Serum PFAS Concentrations to Birth Size in an African American Maternal–Child Cohort

Prenatal serum PFAS concentrations were associated with alterations in maternal DNA methylation, which in turn were associated with infant birth size, which in turn was associated with infant birth size.

You-Ran Tan, Anne L. Dunlop, Todd M. Everson et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.